1:35pm ET
Health and Healthcare
Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict
Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol drug patent.
AMGN Coverage Page 26
8:05am ET
Health and Healthcare
Short Sellers Back Off of Major Biotechs
The February 29 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
5:15pm ET
Health and Healthcare
Why Citi Sees Huge Upside in 4 Top Biotechs Now
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four of the largest names within the biotech space.
8:46am ET
Health and Healthcare
Short Interest Rises Across the Board in Major Biotechs
The February 12 short interest data have been compared with the previous report, and short interest increased across the board in these selected biotech stocks.
8:40am ET
Health and Healthcare
Major Biotech Short Interest Continues to Be Mixed
The January 29 short interest data have been compared with the previous report, and short interest was mixed in most of the selected biotech stocks.
9:50am ET
Health and Healthcare
The 4 Largest Biotech Stocks Are Cheaper Than S&P 500
A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the S&P for the first time since early in 2011, despite displaying higher…
4:31pm ET
Health and Healthcare
Amgen Posts Handy Beat on Estimates and Guidance
Amgen reported better-than-expected fourth-quarter financial results after the markets closed Thursday.
Chris Lange 8:35am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
11:45am ET
Health and Healthcare
Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks with an Outperform rating.
8:35am ET
Health and Healthcare
Short Interest Remains Mixed for Major Biotechs
The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
10:02am ET
Investing
10 Top 2016 Stock Picks From Goldman Sachs, Merrill Lynch and Other Key Analysts
Which well-known and large cap stocks to do the major analysts on Wall Street like for 2016? Here are 10.
8:35am ET
Investing
5 Top Goldman Sachs Stocks to Buy for 2016
Goldman Sachs has seen many top stocks offering great rewards for 2016. The reason may be different for each, but these are what the wealthiest and most sophisticated investors have been told…
8:40am ET
Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
The short interest data are out for the December 15 settlement date, and short interest continued to be mixed in these selected biotech stocks.
12:15pm ET
Investing
4 High-Flying Stocks That Could Fly Even Higher in 2016
Here are four stocks that, while expensive at current levels, have fundamentals good enough to continue and even exceed their success in 2015 through next year.
Trey Thoelcke 7:10am ET
Health and Healthcare
4 Top Biotech Stocks for 2016
Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better 2016 for this exciting sector?